These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 25292074

  • 21. Expression of DNA methylation marker of paired-like homeodomain transcription factor 2 and growth receptors in invasive ductal carcinoma of the breast.
    Wan Abdul Rahman WF, Fauzi MH, Jaafar H.
    Asian Pac J Cancer Prev; 2014; 15(19):8441-5. PubMed ID: 25339043
    [Abstract] [Full Text] [Related]

  • 22. Tumor Angiogenesis in Breast Cancer: Pericytes and Maturation Does Not Correlate With Lymph Node Metastasis and Molecular Subtypes.
    Shrivastav S, Bal A, Singh G, Joshi K.
    Clin Breast Cancer; 2016 Apr; 16(2):131-8. PubMed ID: 26452314
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Breast cancer and thyroid diseases: analysis of 867 consecutive cases.
    Chiappa C, Rovera F, Rausei S, Del Ferraro S, Fachinetti A, Lavazza M, Marchionini V, Arlant V, Tanda ML, Piantanida E, Kim HY, Anuwong A, Dionigi G.
    J Endocrinol Invest; 2017 Feb; 40(2):179-184. PubMed ID: 27624298
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.
    Jung NY, Kim SH, Choi BB, Kim SH, Sung MS.
    World J Surg Oncol; 2015 Mar 15; 13():113. PubMed ID: 25889560
    [Abstract] [Full Text] [Related]

  • 29. Correlation between hormone receptor status and age, and its prognostic implications in breast cancer patients in Bahrain.
    AlZaman AS, Mughal SA, AlZaman YS, AlZaman ES.
    Saudi Med J; 2016 Jan 15; 37(1):37-42. PubMed ID: 26739972
    [Abstract] [Full Text] [Related]

  • 30. Predictors of early distant metastasis in women with breast cancer.
    Rosa Mendoza ES, Moreno E, Caguioa PB.
    J Cancer Res Clin Oncol; 2013 Apr 15; 139(4):645-52. PubMed ID: 23283528
    [Abstract] [Full Text] [Related]

  • 31. Hormone receptor and HER2 status in patients with breast cancer by races in southeastern Turkey.
    Kuzhan A, Adli M, Eryigit Alkis H, Caglayan D.
    J BUON; 2013 Apr 15; 18(3):619-22. PubMed ID: 24065473
    [Abstract] [Full Text] [Related]

  • 32. Ki67 Frequency in Breast Cancers without Axillary Lymph Node Involvement and its Relation with Disease-free Survival.
    Shandiz FH, Shabahang H, Afzaljavan F, Sharifi N, Tavasoli A, Afzalaghaee M, Roshanzamir E, Pasdar A.
    Asian Pac J Cancer Prev; 2016 Apr 15; 17(3):1347-50. PubMed ID: 27039770
    [Abstract] [Full Text] [Related]

  • 33. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.
    Amirifard N, Sadeghi E.
    Asian Pac J Cancer Prev; 2016 Apr 15; 17(5):2593-6. PubMed ID: 27268636
    [Abstract] [Full Text] [Related]

  • 34. Prevalence of known prognostic factors in female breast carcinoma including oestrogen receptor, progesterone receptor and Her-2/neu status--a study in a tertiary care centre.
    Chakrabarti S, Karmakar R, Barui G, Maity PK, Bandyopadhyay A, Roy A.
    J Indian Med Assoc; 2012 Dec 15; 110(12):876-9. PubMed ID: 23936949
    [Abstract] [Full Text] [Related]

  • 35. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [Abstract] [Full Text] [Related]

  • 36. [Immunohistochemical investigation of steroid hormones (ER, PR) in breast cancer].
    Mchedlishvili MIu, Gabunia UA, Makharoblidze ER, Burnadze KT, Piradashvili DZ.
    Georgian Med News; 2005 Feb 01; (119):65-7. PubMed ID: 15834186
    [Abstract] [Full Text] [Related]

  • 37. A clinical and pathological study of triple negative breast carcinoma: experience of a tertiary care centre in eastern India.
    Sen S, Gayen R, Das S, Maitra S, Jha A, Mahata M.
    J Indian Med Assoc; 2012 Oct 01; 110(10):686-9, 705. PubMed ID: 23738399
    [Abstract] [Full Text] [Related]

  • 38. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
    Yan J, Liu XL, Han LZ, Xiao G, Li NL, Deng YN, Yin LC, Ling LJ, Yu XY, Tan CL, Huang XP, Liu LX.
    Asian Pac J Cancer Prev; 2015 Oct 01; 16(2):823-9. PubMed ID: 25684532
    [Abstract] [Full Text] [Related]

  • 39. Young investigator challenge: The utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions.
    Lew M, Pang JC, Jing X, Fields KL, Roh MH.
    Cancer Cytopathol; 2015 Oct 01; 123(10):576-81. PubMed ID: 26465236
    [Abstract] [Full Text] [Related]

  • 40. Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypes.
    Kos T, Aksoy S, Sendur MA, Arik Z, Civelek B, Kandemir N, Ozdemir NY, Zengin N, Altundag K.
    J BUON; 2013 Oct 01; 18(3):608-13. PubMed ID: 24065471
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.